|
WO1994029459A1
(en)
|
1993-06-04 |
1994-12-22 |
Whitehead Institute For Biomedical Research |
Stress proteins and uses therefor
|
|
US5133974A
(en)
*
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
CA2185826C
(en)
|
1994-03-21 |
2007-06-19 |
Stephen Mark Anderton |
Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
HU222994B1
(hu)
|
1995-11-02 |
2004-01-28 |
BIOREX Kutató és Fejlesztő Rt. |
Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
|
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
IN183280B
(https=)
|
1996-09-20 |
1999-10-30 |
Univ New Mexico |
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
CZ20002669A3
(cs)
|
1998-01-23 |
2001-11-14 |
National Jewish Medical And Research Center |
Pouľití proteinů tepelného ąoku nebo molekuly nukleové kyseliny, která jej kóduje, přípravek tyto látky obsahující, způsob výběru léčby přecitlivělosti nebo nedostatečnosti průchodu dýchacích cest
|
|
JP4768122B2
(ja)
|
1998-02-20 |
2011-09-07 |
ユニバーシティー オブ マイアミ |
改変型熱ショックタンパク質−抗原性ペプチド複合体
|
|
US7396681B1
(en)
|
1998-03-27 |
2008-07-08 |
Gabriele Multhoff |
Application of Hsp70 proteins
|
|
FR2777890B1
(fr)
|
1998-04-22 |
2000-12-29 |
Roussy Inst Gustave |
Composes peptidiques d'hsp70 utiles dans l'immunotherapie du cancer
|
|
US6274597B1
(en)
|
1998-06-01 |
2001-08-14 |
Mount Sinai School Of Medicine Of New York University |
Method of enhancing lysosomal α-Galactosidase A
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
HU226617B1
(en)
|
1998-12-14 |
2009-04-28 |
Cytrx Corp |
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
|
|
HUP9900475D0
(en)
*
|
1999-02-26 |
1999-04-28 |
Biorex Kutato Fejlesztoe Kft |
O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
|
|
CA2383213A1
(en)
|
1999-09-10 |
2001-03-15 |
Fordham University |
Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
|
|
US20020039583A1
(en)
|
1999-09-30 |
2002-04-04 |
Subjeck John R. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US20030236300A1
(en)
|
1999-10-27 |
2003-12-25 |
Yale University |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
AU1582801A
(en)
|
1999-11-05 |
2001-06-06 |
Board Of Regents Of The University Of Nebraska, The |
Methods and compositions for protection against bovine herpesvirus
|
|
US6964851B2
(en)
|
1999-12-07 |
2005-11-15 |
Stressgen Biotechnologies Corp. |
Compositions and methods for detecting stress-inducible proteins
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20020127219A1
(en)
|
1999-12-30 |
2002-09-12 |
Okkels Jens Sigurd |
Lysosomal enzymes and lysosomal enzyme activators
|
|
US20010034042A1
(en)
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
AU2001229597A1
(en)
|
2000-01-21 |
2001-07-31 |
University Of Connecticut Health Center |
Compositions and methods to treat neurodegenerative disorders
|
|
AU2001227960A1
(en)
|
2000-01-21 |
2001-07-31 |
University Of Connecticut Health Center |
Heat shock/stress protein complexes as vaccines against neurodegenerative disorders
|
|
HUP0001583A2
(hu)
|
2000-04-18 |
2002-11-28 |
BIOREX Kutató és Fejlesztő Rt. |
Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
|
|
WO2001097829A2
(en)
|
2000-06-19 |
2001-12-27 |
Genzyme Corporation |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
WO2002011669A2
(en)
|
2000-08-07 |
2002-02-14 |
Antigenics, Llc |
Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
|
|
ATE430161T1
(de)
|
2000-09-13 |
2009-05-15 |
Multimmune Gmbh |
Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
|
|
CA2422867A1
(en)
|
2000-09-15 |
2002-04-25 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
|
US20020119163A1
(en)
|
2000-11-03 |
2002-08-29 |
The Board Of Regents Of The University Of Nebraska |
Methods and compositions for protection against bovine viral deseases
|
|
EP1209226A3
(en)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
|
|
US20020142299A1
(en)
|
2001-01-09 |
2002-10-03 |
Davidson Beverly L. |
PTD-modified proteins
|
|
CA2438750A1
(en)
|
2001-02-20 |
2002-08-29 |
Uab Research Foundation |
Aminoglycoside treatment for lysosomal storage diseases
|
|
HK1079705A1
(zh)
|
2001-08-20 |
2006-04-13 |
University Of Connecticut Health Center |
包含用於治疗癌症及感染性疾病的热休克蛋白或α2-巨球蛋白的组合物制备方法
|
|
US20050267020A1
(en)
|
2001-09-27 |
2005-12-01 |
Olivier Faure |
Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
|
|
HU0103939D0
(en)
|
2001-09-27 |
2001-11-28 |
Biorex Kutato Fejlesztoe Kft |
Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
|
|
GB0123756D0
(en)
|
2001-10-03 |
2001-11-21 |
King S College London |
A novel chaperone-type of adjuvant for vaccination - Basic 1
|
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
|
ITMI20012573A1
(it)
|
2001-12-06 |
2003-06-06 |
D B P Dev Biotechonologica L P |
Gli acilsalicilati:una nuova classe di induttori di risposta heat shock
|
|
WO2003057664A1
(en)
|
2002-01-11 |
2003-07-17 |
Biorex Kutató És Fejlesztö Rt. |
Carboxamidine derivatives and their use in the treatment of vascular diseases
|
|
AU2003218639A1
(en)
|
2002-01-24 |
2003-09-02 |
Universiteit Gent |
Tumour treatment compositions comprising hsp70 and tumour necrosis factor
|
|
WO2003068941A2
(en)
|
2002-02-13 |
2003-08-21 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
IL148401A0
(en)
|
2002-02-26 |
2002-09-12 |
Hadasit Med Res Service |
Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
|
|
AU2003224880A1
(en)
|
2002-04-05 |
2003-10-27 |
Genzyme Corporation |
Methods of enhancing lysosomal storage disease therapy
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
WO2003090686A2
(en)
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
WO2003092624A2
(en)
|
2002-05-02 |
2003-11-13 |
University Of Connecticut Health Center |
Use of heat shock proteins to enhance efficacy of antibody therapeutics
|
|
EP1539223A2
(en)
|
2002-05-02 |
2005-06-15 |
University of Connecticut Health Center |
Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines comprising heat shock protein-peptide complexes or alpha-2-macroglobulin-peptide complexes
|
|
WO2004024097A2
(en)
|
2002-09-16 |
2004-03-25 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
DK1625148T3
(da)
|
2003-05-21 |
2013-01-14 |
Biotech Tools Sa |
Peptidkompleks
|
|
US7244616B2
(en)
|
2003-06-27 |
2007-07-17 |
Bayer Pharmaceuticals Corporation |
Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
|
|
HUP0303584A3
(en)
|
2003-10-30 |
2009-12-28 |
Cytrx Corp |
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
|
|
DE60335549D1
(de)
|
2003-11-12 |
2011-02-10 |
Alfa Biogene Internat B V |
Gewinnung von Hitzeschockproteinen
|
|
JP2007514661A
(ja)
|
2003-11-25 |
2007-06-07 |
マウント シナイ スクール オブ メディスン オブ ニューヨーク ユニバーシティー |
ニーマンピック病のシャペロンに基づく治療方法
|
|
ES2484340T3
(es)
|
2003-12-05 |
2014-08-11 |
Multimmune Gmbh |
Anticuerpos anti hsp70 terapéuticos y diagnósticos
|
|
WO2005102272A2
(en)
*
|
2004-04-21 |
2005-11-03 |
Pfizer Products Inc. |
Sustained-release dosage forms for cabergoline
|
|
JP2005306778A
(ja)
|
2004-04-21 |
2005-11-04 |
Basf Ag |
徐放性製剤及びその製造方法
|
|
US20060009520A1
(en)
|
2004-05-12 |
2006-01-12 |
Tall Alan R |
Retinoid-based methods for altering macrophage cholesterol
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
US7270305B2
(en)
|
2004-06-15 |
2007-09-18 |
The Boeing Company |
Aircraft leading edge apparatuses and corresponding methods
|
|
EA200700388A1
(ru)
|
2004-08-13 |
2007-08-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ её изготовления и её применение
|
|
WO2006062402A2
(en)
|
2004-12-10 |
2006-06-15 |
Zernike Business Support B.V. |
Heat shock proteins (hsp) and supraventricular arrhythmia
|
|
CN101541172A
(zh)
|
2005-06-08 |
2009-09-23 |
阿米库斯治疗学公司 |
溶酶体酶编码基因突变相关的cns紊乱的治疗
|
|
WO2007041285A2
(en)
|
2005-09-29 |
2007-04-12 |
Viral Genetics, Inc. |
Complexes of inactivated pepsin fraction and heat shock protein
|
|
CN102775396B
(zh)
|
2005-11-08 |
2014-10-08 |
沃泰克斯药物股份有限公司 |
Atp-结合弹夹转运蛋白的杂环调控剂
|
|
US20080039400A1
(en)
|
2006-01-24 |
2008-02-14 |
Universiteit Utrecht Uu Holding B.V. |
Treatment and prevention of inflammatory bowel diseases
|
|
NZ570103A
(en)
|
2006-01-26 |
2011-11-25 |
Foldrx Pharmaceuticals Inc |
Compounds and methods for modulating protein trafficking
|
|
CA2653052A1
(en)
|
2006-05-19 |
2007-11-29 |
The Scripps Research Institute |
Treatment of protein misfolding
|
|
JP5303458B2
(ja)
|
2006-06-23 |
2013-10-02 |
アミークス セラピューティックス インコーポレイテッド |
β−グルコセレブロシダーゼの活性増強による神経学的疾患の治療方法
|
|
US10336757B2
(en)
|
2006-06-30 |
2019-07-02 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases through inhibition of HSP90
|
|
TW200824678A
(en)
|
2006-08-11 |
2008-06-16 |
Combinatorx Inc |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
EP2057195A4
(en)
|
2006-08-29 |
2010-05-12 |
Forhumantech Co Ltd |
PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME
|
|
WO2008039514A1
(en)
*
|
2006-09-26 |
2008-04-03 |
Cytrx Corporation |
Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
|
|
AU2007328280A1
(en)
|
2006-12-01 |
2008-06-12 |
Cytrx Corporation |
Hydroxylamine derivatives for the treatment of stroke
|
|
EP2132309A4
(en)
|
2007-02-23 |
2011-01-05 |
Univ Florida |
COMPOSITIONS AND METHODS OF TREATING GLYCOLOGICAL MEMORY DISEASES
|
|
WO2008112525A2
(en)
|
2007-03-09 |
2008-09-18 |
Link Medicine Corporation |
Treatment of lysosomal storage diseases
|
|
GB0705626D0
(en)
|
2007-03-23 |
2007-05-02 |
Royal Veterinary College |
Method for enhancing sperm survival
|
|
CA2682350A1
(en)
|
2007-04-11 |
2008-10-23 |
The Jackson Laboratory |
Diagnosis and treatment of diseases caused by misfolded proteins
|
|
US8399525B2
(en)
|
2007-04-13 |
2013-03-19 |
Amicus Therapeutics, Inc. |
Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers
|
|
PL2148661T3
(pl)
|
2007-04-25 |
2013-07-31 |
Cytochroma Inc |
Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik
|
|
EP2586428B1
(en)
|
2007-04-26 |
2023-11-08 |
Sublimity Therapeutics Limited |
Manufacture of multiple minicapsules
|
|
EP2150254A4
(en)
|
2007-04-26 |
2010-11-10 |
Amicus Therapeutics Inc |
DOSAGES FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES WITH PHARMACOLOGICAL CHAPTERONES
|
|
TW200901958A
(en)
*
|
2007-05-04 |
2009-01-16 |
Cytrx Corp |
Diabetic wound healing
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
|
US8742068B2
(en)
|
2007-07-06 |
2014-06-03 |
Universiteit Utrecht Holding B.V. |
Treatment and prevention of inflammatory diseases and autoimmune diseases
|
|
JP2010538655A
(ja)
|
2007-09-12 |
2010-12-16 |
アナフォア インコーポレイテッド |
自己免疫疾患についてのｈｓｐ７０に基づく治療
|
|
EP2252288A1
(en)
|
2007-11-21 |
2010-11-24 |
Summit Corporation Plc |
Treatment of protein folding disorders
|
|
BRPI0822349A2
(pt)
|
2007-11-29 |
2019-09-24 |
Neuraltus Pharmaceuticals Inc |
composições e métodos para tratar doenças lisossômicas
|
|
KR20100131992A
(ko)
|
2008-01-30 |
2010-12-16 |
제론 코포레이션 |
화학 합성 배지에서 세포를 배양하기 위한 합성 표면
|
|
WO2009095452A1
(en)
|
2008-01-31 |
2009-08-06 |
Crystax Pharmaceuticals, S.L. |
Crystal structure of the atpase domain of proteins of the hsp70 family
|
|
CA2712593A1
(en)
|
2008-02-01 |
2009-08-13 |
The Scripps Research Institute |
Methods for treating a condition characterized by dysfunction in protein homeostasis
|
|
HRP20170698T1
(hr)
|
2008-05-07 |
2017-09-22 |
Biomarin Pharmaceutical Inc. |
Lizosomski usmjereni peptidi i njihove uporabe
|
|
WO2009137796A2
(en)
|
2008-05-08 |
2009-11-12 |
Northwestern University |
Method of regulating the heat shock response
|
|
GB0809360D0
(en)
|
2008-05-22 |
2008-07-02 |
Isis Innovation |
Calcium modulation
|
|
AU2009262670B2
(en)
|
2008-06-26 |
2013-06-20 |
Zevra Denmark A/S |
Use of Hsp70 as a regulator of enzymatic activity
|
|
EP2323652A2
(en)
|
2008-08-06 |
2011-05-25 |
Summit Corporation Plc |
Treatment of lysosomal storage disorders and other proteostatic diseases
|
|
WO2010022461A1
(en)
|
2008-08-29 |
2010-03-04 |
Children, Youth And Women's Health Service |
Sulphated sugars to increase activity of sulphatases en lysosomal storage disorders
|
|
AR073709A1
(es)
|
2008-09-29 |
2010-11-24 |
Vertex Pharma |
Unidades de dosis de acido 3-(6-(1-(2,2-difluorobenzeno (d) (1,3) dioxol-5-il) ciclopropancarboxamido)-3-metilpiridin-2-il) benzoico
|
|
WO2010053655A2
(en)
|
2008-11-07 |
2010-05-14 |
University Of Kansas |
Therapeutic methods with withaferin a and analogs
|
|
WO2010086418A1
(en)
|
2009-01-29 |
2010-08-05 |
Alfa Biogene International B.V. |
Functional food product comprising heat shock protein or a hydrolysate thereof
|
|
EP2218458A1
(en)
|
2009-02-13 |
2010-08-18 |
Fondazione Telethon |
Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
|
|
US8932571B2
(en)
|
2009-03-10 |
2015-01-13 |
Alfa Biogene International B.V. |
Skin care product
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
EP2475376B1
(en)
|
2009-06-17 |
2016-03-30 |
BioMarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
AU2010281403B2
(en)
|
2009-07-28 |
2016-03-10 |
Takeda Pharmaceutical Company Limited |
Compositions and methods for treating Gaucher disease
|
|
WO2011019763A2
(en)
|
2009-08-10 |
2011-02-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
|
|
US20110081428A1
(en)
|
2009-09-16 |
2011-04-07 |
The Buck Institute For Age Research |
Use of thioflavin-like compounds to increase life span and/or health span
|
|
US8609416B2
(en)
|
2009-12-18 |
2013-12-17 |
Ventria Bioscience |
Methods and compositions comprising heat shock proteins
|
|
JP6045347B2
(ja)
|
2010-02-03 |
2016-12-14 |
ファーマ ツー ビー リミテッド |
ラサギリンの持続放出性製剤およびその使用
|
|
ES2688072T3
(es)
*
|
2010-05-11 |
2018-10-30 |
Mallinckrodt Ard Ip Limited |
ACTH para el tratamiento de la esclerosis lateral amiotrófica
|
|
WO2012012656A2
(en)
|
2010-07-21 |
2012-01-26 |
University Of South Florida |
Materials and methods for treating neurodegenerative diseases
|
|
CA2817773A1
(en)
|
2010-11-30 |
2012-06-07 |
Orphazyme Aps |
Methods for increasing intracellular activity of hsp70
|
|
WO2013006076A1
(en)
|
2011-07-04 |
2013-01-10 |
New York University |
The use of intranasally administered hsp70 protein to treat neurodegenerative diseases
|
|
JP6368242B2
(ja)
*
|
2011-10-06 |
2018-08-01 |
ノバルティス アーゲー |
４０−ｏ−（２−ヒドロキシ）エチル−ラパマイシンを含む医薬組成物
|
|
WO2013148333A1
(en)
|
2012-03-28 |
2013-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Salicylic acid derivatives useful as glucocerebrosidase activators
|
|
JP2016503405A
(ja)
|
2012-11-05 |
2016-02-04 |
ジェンザイム・コーポレーション |
タンパク質症を処置するための組成物および方法
|
|
AU2015317447B2
(en)
|
2014-09-15 |
2021-02-25 |
Zevra Denmark A/S |
Arimoclomol formulation
|
|
MX2019013835A
(es)
|
2017-05-24 |
2020-07-14 |
Orphazyme As |
Inductores de proteinas de choque termico y trastornos frontotemporales.
|